Back | Next |
home / stock / gdrx / gdrx message board
Subject | By | Source | When |
---|---|---|---|
+500shares at 35.72 | jablome | investorshub | 11/17/2020 9:35:07 PM |
2k at 36.04 | jablome | investorshub | 11/17/2020 8:57:26 PM |
About GoodRx | @LaughinPaulRyan | investorshub | 11/17/2020 1:29:17 PM |
GoodRx Holdings Inc. (Nasdaq: $GDRX), a leading consumer-focused | @LaughinPaulRyan | investorshub | 11/17/2020 1:28:59 PM |
GoodRx Holdings Inc ($GDRX) | @LaughinPaulRyan | investorshub | 11/17/2020 1:27:53 PM |
In for a quick over night bounce | T695 | investorshub | 10/01/2020 8:45:56 PM |
gdrx chart | TREND1 | investorshub | 09/25/2020 8:56:43 PM |
$GDRX Sorry. This chart is for me. | TREND1 | investorshub | 09/24/2020 8:35:12 PM |
$GDRX CHART | TREND1 | investorshub | 09/24/2020 5:36:09 PM |
Trump is to $GDRX as Elon Musk is | crudeoil24 | investorshub | 09/24/2020 11:46:03 AM |
Trump's recent negotiations with big pharma is huge | crudeoil24 | investorshub | 09/24/2020 11:45:16 AM |
Great profitable company though | T695 | investorshub | 09/24/2020 11:43:43 AM |
No hes not, if anything if theres wal | T695 | investorshub | 09/24/2020 11:42:24 AM |
President Trump is a huge macroeconomic catalyst for $GDRX. | crudeoil24 | investorshub | 09/24/2020 11:38:02 AM |
Hes not their negotiator, Trump has nothing to | T695 | investorshub | 09/24/2020 11:34:42 AM |
They have President Trump as a negotiator. He | crudeoil24 | investorshub | 09/23/2020 8:45:31 PM |
Free Prescription Coupons - Official GoodRx Site | TREND1 | investorshub | 09/23/2020 8:32:55 PM |
How is it able to offer the discounts ? | TREND1 | investorshub | 09/23/2020 8:30:49 PM |
Company is now flushed with cash....well over | crudeoil24 | investorshub | 09/23/2020 8:25:56 PM |
$GDRX IPO | TREND1 | investorshub | 09/23/2020 8:02:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-po...
2024-06-10 07:00:04 ET Craig Hettenbach from Morgan Stanley issued a price target of $9.50 for GDRX on 2024-06-10 05:32:00. The adjusted price target was set to $9.50. At the time of the announcement, GDRX was trading at $8.55. The overall price target consensus is at $1...
2024-05-31 07:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...